Bank of America’s CARGO Therapeutics CRGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-48,907
Closed -$201K 8363
2025
Q2
$201K Sell
48,907
-37,117
-43% -$159K ﹤0.01% 6185
2025
Q1
$350K Buy
86,024
+24,875
+41% +$167K ﹤0.01% 5854
2024
Q4
$882K Buy
61,149
+1,454
+2% +$26.4K ﹤0.01% 5141
2024
Q3
$1.1M Buy
59,695
+17,576
+42% +$314K ﹤0.01% 5000
2024
Q2
$692K Buy
42,119
+19,838
+89% +$377K ﹤0.01% 5140
2024
Q1
$497K Buy
22,281
+18,665
+516% +$444K ﹤0.01% 5352
2023
Q4
$83.7K Buy
+3,616
New +$61.3K ﹤0.01% 6447

Other funds holding CRGX

Bank of America's CRGX Position: Q3 2025 in Review

Bank of America sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 48,907 shares — an estimated $201K sold.

Bank of America first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $1.1M in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Bank of America reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 48,907 CARGO Therapeutics shares in Q3 2025, an estimated $201K.
  • Bank of America first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
  • Bank of America's CARGO Therapeutics position peaked at $1.1M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.